Stanford University researchers have developed aptamer-antibody chimeras that achieve dynamic, sensitive, and specific biomolecule sensing beyond the capacity of antibodies or aptamers alone.
Researchers in Prof. Karl Deisseroth's laboratory have patented a revolutionary technique that can be utilized to map neural circuits in the whole brain.
Multiplexed analysis of biological components is critical for classifying molecular subtypes of heterogeneous tumors to provide patient-specific therapies.
Engineers at Stanford have invented a smart toilet platform that will autonomously monitor excreted waste from humans. We describe easily deployable hardware and software for the long-term analysis of a user's excreta through data collection and models of human health.
This nanoparticle platform for electric field detection is the first inorganic platform to use both intensity and spectro-ratiometric (relative color change) readout for the determination of local electric fields in vitro, in vivo, and in situ.
Running chemotherapeutic drug screens on tumor biopsies ex vivo has the potential to increase patient survival by personally matching them to the drug which is the most effective against their particular tumor.
Researchers at the Solgaard Lab have demonstrated that light sheet fluorescence microscopy (LSFM) with structured and pivoting illumination enables fast image acquisition and improved image quality.
W.E. Moerner and Adam Cohen have patented the Anti-Brownian ELectrokinetic trap (ABEL trap) which can trap, measure, and manipulate sub-micron objects (e.g. single molecules) in solution at ambient temperature.